https://youtu.be/rmBaTesxACc
Videos
Gastroparesis and GLP-1s: Why Everyone Is Talking About This Digestive Disorder
Gastroparesis is a condition where the stomach empties food much more slowly than it should, even though there isn’t a blockage. As food sits in the stomach longer, people may experience nausea, vomiting, bloating, feeling full after just a few bites, abdominal pain, and sometimes weight loss.
What Does The GLP-1 Mental Health Connection Mean For Patients?
https://www.youtube.com/watch?v=klKPjylGRNM
A New Treatment for Aggressive Breast Cancer
Researchers tested a new combination of two cancer drugs — sacituzumab govitecan and pembrolizumab — as the first treatment for patients with PD-L1-positive advanced TNBC. PD-L1 is a protein on some cancer cells that interacts with the immune system.
More Research is needed for Advanced Endometrial Cancer
For patients with advanced endometrial cancer who have already gone through chemotherapy and immunotherapy, options can be very limited. This study suggests sacituzumab govitecan may offer another potential strategy.
The Safety of a New Weight Loss Combo Treatment
The safety profile was generally consistent with what is already known about these medications.
Gastrointestinal side effects, such as nausea, were seen, which are common with GLP-1 drugs like semaglutide. Adverse events were closely monitored throughout the study.